$CELG News Celgene stock price target cut to $120 from

New Post Public Reply Private Reply Replies (0) Message Board

Jan 29, 2016 at 12:14 PM

$CELG News

Celgene stock price target cut to $120 from $130 at Barclays 8:23 a.m. Today - Tomi Kilgore
Why this big baby of a market won’t calm down anytime soon 9:23 a.m. Jan. 28, 2016 - Victor Reklaitis
Celgene earnings miss as costs offset price hike 8:42 a.m. Jan. 28, 2016 - MarketWatch.com
Apple, Amazon headline crucial week for Wall Street quarterly results 6:21 a.m. Jan. 25, 2016 - Wallace Witkowski
Celgene started at outperform with $149 stock price target at Credit Suisse 8:16 a.m. Jan. 20, 2016 - Tomi Kilgore
10 biotech stocks to buy at ‘silly’ cheap prices 10:15 a.m. Jan. 18, 2016 - Michael Brush
As biotech stocks knife under their ‘Hillary’ low, analysts still say buy ’em 7:27 a.m. Jan. 12, 2016 - Victor Reklaitis
Celgene names new CEO, cuts 2015 outlook 1:45 p.m. Jan. 11, 2016 - MarketWatch.com
Shire agrees to buy Baxalta for $32 billion 8:49 a.m. Jan. 11, 2016 - MarketWatch.com
Shire agrees to buy Baxalta for $32 billion 8:16 a.m. Jan. 11, 2016 - MarketWatch.com
Celgene’s stock rockets as analysts cheer patent settlement 4:40 p.m. Dec. 23, 2015 - Tomi Kilgore
Dow posts triple-digit gain for third session in a row 4:27 p.m. Dec. 23, 2015 - Sara Sjolin
10 stocks that led the S&P 500 higher Wednesday 4:26 p.m. Dec. 23, 2015 - Philip van Doorn
Celgene shares jumps 8.4% in early trade as company settles patent suit 9:34 a.m. Dec. 23, 2015 - Mark DeCambre
Celgene shares lead S&P 500 gainers 9:34 a.m. Dec. 23, 2015 - Mark DeCambre
Celgene's stock surges 8.7% premarket after settlement of Revlimid patent litigation late Tuesday 8:59 a.m. Dec. 23, 2015 - Tomi Kilgore
Bulls ready to break out of the holiday quiet 8:45 a.m. Dec. 23, 2015 - Victor Reklaitis
Celgene shares rally on settlement of patent suit 5:00 p.m. Dec. 22, 2015 - Wallace Witkowski
Celgene shares rally 10% after patent litigation settled 4:45 p.m. Dec. 22, 2015 - Wallace Witkowski
AstraZeneca to buy 55% stake in Acerta Pharma 3:15 a.m. Dec. 17, 2015 - MarketWatch.com

SurModics' (SRDX) Q1 Earnings & Revenues Beat Estimates 34 min ago - Zacks.com
Stock Market News for January 29, 2016 10:10 a.m. Today - Zacks.com
Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook 9:05 a.m. Today - Zacks.com
Biotech ETF (IBB) Hits New 52-Week Low 8:59 a.m. Today - Zacks.com
European Ad Comm backs Bristol-Myers and AbbVie's elotuzumab for multiple myeloma 8:44 a.m. Today - Seeking Alpha
Cramer Likes T-Mobile - Cramer's Lightning Round (1/28/16) 7:16 a.m. Today - Seeking Alpha
Wall Street Breakfast: BOJ Goes Sub-Zero In The Heart Of Winter 6:57 a.m. Today - Seeking Alpha
What To Buy In This Biotech Sell-Off 6:46 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: I'm Buy, Buy, Buying T-Mobile US 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Market 'Trash' Will Make You Money 8:10 p.m. Jan. 28, 2016 - TheStreet.com
Celgene (CELG) Stock Plunged on Earnings Miss 4:52 p.m. Jan. 28, 2016 - TheStreet.com
'The Market Doesn't Know Where It's Headed' 4:02 p.m. Jan. 28, 2016 - TheStreet.com
Celgene Corporation's (CELG) CEO Robert J. Hugin on Q4 2015 Results - Earnings Call Transcript 3:31 p.m. Jan. 28, 2016 - Seeking Alpha
Stocks Back Near Highs in Unsettled Session 2:23 p.m. Jan. 28, 2016 - TheStreet.com
Incyte Halts Phase II Jakafi-Stivarga Combination Study 1:50 p.m. Jan. 28, 2016 - Zacks.com
Abbott Labs (ABT) Beats on Q4 Earnings, Lags on Revenues 11:43 a.m. Jan. 28, 2016 - Zacks.com
Celgene Earnings, Guidance Fail to Live Up to Investor Expectations 11:19 a.m. Jan. 28, 2016 - 247WallSt.com
Celgene Misses on Q4 Earnings, Reiterates 2016 Guidance 10:22 a.m. Jan. 28, 2016 - Zacks.com
Bristol-Myers Beats on Q4 Earnings, Provides 2016 Guidance 10:12 a.m. Jan. 28, 2016 - Zacks.com
Biotech Is the Cheapest Since 2011: 4 Top Stocks to Buy Now 9:39 a.m. Jan. 28, 2016 - 247WallSt.com

OncBioMune Patents a New Promising Approach to Chemotherapy 8:00 a.m. Jan. 28, 2016 - ACCESSWIRE
Technical Recap on Biotechnology Stocks -- Nektar Therapeutics, Novavax, Celgene, and Opko Health 8:01 a.m. Jan. 25, 2016 - ACCESSWIRE
Data Presented at ASCO GI Highlight the Feasibility of Second-Line Treatment in Patients with Metastatic Pancreatic Cancer Who Have Received First-Line Abraxane Plus Gemcitabine 3:31 p.m. Jan. 22, 2016 - BusinessWire - BZX
Be Counted! Campaign Brings Together the Psoriatic Arthritis Community to Increase Understanding of This Chronic, Autoimmune Disease 8:00 a.m. Jan. 22, 2016 - BusinessWire - BZX
Investigational Combinations Using an ABRAXANE and Gemcitabine Foundation Lead ASCO GI Pancreatic Cancer Research 7:30 a.m. Jan. 22, 2016 - BusinessWire - BZX
Covered Call Alerts For Chesapeake Energy, BlackBerry, Nike, AbbVie and Celgene Released By InvestorsObserver 9:31 a.m. Jan. 19, 2016 - PR Newswire - PRF
Organizational Changes Strengthen Leadership Teamand Position Celgene for Long-Term Growth 11:06 a.m. Jan. 11, 2016 - BusinessWire - BZX
Covered Call Alerts For Disney, Celldex Therapeutics, Shake Shack, Dow Chemical and Celgene Released By InvestorsObserver 9:31 a.m. Jan. 6, 2016 - PR Newswire - PRF
Celgene Corporation to Announce Fourth Quarter and Full-Year 2015 Results on January 28, 2016 7:30 a.m. Jan. 5, 2016 - BusinessWire - BZX
Celgene Corporation to Present at the 34th Annual J.P. Morgan Healthcare Conference 7:30 a.m. Jan. 4, 2016 - BusinessWire - BZX
Covered Call Alerts For Kinder Morgan, Rite Aid, Celgene, ConocoPhillips and Amazon.com Released By InvestorsObserver 9:31 a.m. Dec. 24, 2015 - PR Newswire - PRF
Oral REVLIMID® Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan 1:00 a.m. Dec. 21, 2015 - BusinessWire - BZX
Covered Call Alerts For Fitbit, Corning Inc., Celgene, CSX and Adobe Systems Released By InvestorsObserver 9:31 a.m. Dec. 14, 2015 - PR Newswire - PRF
BioSig Technologies, Inc. Issues Special Letter to Shareholders 8:01 a.m. Dec. 9, 2015 - Marketwired
Abstracts at San Antonio Breast Cancer Symposium Highlight ABRAXANE® as a Potential Backbone Therapy in Neoadjuvant and Triple-Negative-Breast Cancer 7:30 a.m. Dec. 9, 2015 - BusinessWire - BZX
Story Behind the Charts - Research on Celgene, United Continental Holdings, Yahoo! and Twitter 8:30 a.m. Dec. 8, 2015 - ACCESSWIRE
FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Lower-Risk Myelodysplastic Syndromes 7:00 a.m. Dec. 7, 2015 - BusinessWire - BZX
IMiD® Combination Therapies Form Backbone of Multiple Myeloma Research at ASH 7:00 a.m. Dec. 6, 2015 - BusinessWire - BZX
Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition 12:30 p.m. Dec. 5, 2015 - BusinessWire - BZX
Study of Bortezomib Added to Revlimid® and Dexamethasone Backbone Therapy Presented at ASH 10:53 a.m. Dec. 5, 2015 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Paris Baguette Pioneers Drive-Thru in Oklahoma

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Historic Records Set at 2026 CNO Monumental Marathon

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

2027 Toy of the Year Finalists Energize Play Market

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Boston STEM Expo Sparks Young Minds in Engineering

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

JOYEE N01 Kicks Off Global Launch with African Orders

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

FuelCell Faces Class Action Crunch as Deadline Looms

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Adding Fireplaces: Home Comfort or Construction Headache?

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...